Guanfacine
Back to searchMolecule Structure
Scientific Name
Guanfacine
Description of the Drug
Guanfacine is an alpha-2A adrenergic receptor agonist used to treat ADHD.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01018
http://www.drugbank.ca/drugs/DB01018
Brand Name(s)
Intuniv
Company Owner(s)
Epic Pharma Llc, Apotex Inc, Takeda Pharmaceuticals Usa Inc, Sandoz Inc, Sun Pharmaceutical Industries Ltd, Watson Laboratories Inc, Twi Pharmaceuticals Inc, Actavis Elizabeth Llc, Teva Pharmaceuticals Usa, Yichang Humanwell Pharmaceutical Co Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Adrenergic receptor alpha-2 | PROTEIN FAMILY | AGONIST | CHEMBL2095158 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL35094 | ||
PharmGKB | PA449825 | ||
Human Metabolome Database | HMDB0015153 | ||
DrugBank | DB01018 | ||
PubChem: Thomson Pharma | 15391685 | ||
PubChem | 3519 | ||
LINCS | LSM-2716 | ||
Nikkaji | J21.225C | ||
BindingDB | 81984 | ||
EPA CompTox Dashboard | DTXSID9046944 | ||
DrugCentral | 1343 | ||
ChemicalBook | CB3875216 | CB72509249 | |
Guide to Pharmacology | 522 | ||
rxnorm | INTUNIV | GUANFACINE | GUANFACINE HYDROCHLORIDE |
KEGG Ligand | C07037 | ||
ChEBI | 5558 | ||
ZINC | ZINC000003872738 |